These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9892302)

  • 1. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Dunn L; Peszke M; Cramer J; Xu W; Thomas J; Charney D
    Am J Psychiatry; 1999 Jan; 156(1):88-93. PubMed ID: 9892302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D
    N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.
    Buchanan RW; Breier A; Kirkpatrick B; Ball P; Carpenter WT
    Am J Psychiatry; 1998 Jun; 155(6):751-60. PubMed ID: 9619146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Grabowski J; Douyon R; Thomas J; Henderson W; Charney D
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1237-61. PubMed ID: 9865219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of differential response to clozapine and haloperidol. Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Lawson W; Crayton J; Cramer J; Xu W; Thomas J; Stolar M; Charney D
    Biol Psychiatry; 1998 Sep; 44(6):475-82. PubMed ID: 9777179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.
    Breier A; Buchanan RW; Kirkpatrick B; Davis OR; Irish D; Summerfelt A; Carpenter WT
    Am J Psychiatry; 1994 Jan; 151(1):20-6. PubMed ID: 8267129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does participation in psychosocial treatment augment the benefit of clozapine? Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Tekell J; Peters J; Cramer J; Fontana A; Xu W; Thomas J; Henderson W; Charney D
    Arch Gen Psychiatry; 1998 Jul; 55(7):618-25. PubMed ID: 9672052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Jurgis G; Perlick D; Xu W; Thomas J; Henderson W; Charney D
    J Clin Psychiatry; 2000 Sep; 61(9):671-6. PubMed ID: 11030488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trial.
    Ghaleiha A; Honarbakhsh N; Boroumand MA; Jafarinia M; Tabrizi M; Rezaei F; Raznahan M; Akhondzadeh S
    Hum Psychopharmacol; 2011 Mar; 26(2):120-4. PubMed ID: 21412846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Allan E; Erdos J; Frisman LK; Xu W; Thomas J; Henderson W; Charney D
    Arch Gen Psychiatry; 1999 Jun; 56(6):565-72. PubMed ID: 10359474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting improvement in quality of life and symptomatology in schizophrenia.
    Cramer J; Rosenheck R; Xu W; Henderson W; Thomas J; Charney D;
    Schizophr Bull; 2001; 27(2):227-34. PubMed ID: 11354590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia.
    Rosenheck R; Evans D; Herz L; Cramer J; Xu W; Thomas J; Henderson W; Charney D
    Schizophr Bull; 1999; 25(4):709-19. PubMed ID: 10667741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrete state analysis for interpretation of data from clinical trials.
    Sugar CA; James GM; Lenert LA; Rosenheck RA
    Med Care; 2004 Feb; 42(2):183-96. PubMed ID: 14734956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of clozapine on weight: a controlled study.
    Bustillo JR; Buchanan RW; Irish D; Breier A
    Am J Psychiatry; 1996 Jun; 153(6):817-9. PubMed ID: 8633697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine's effect on negative symptoms in treatment-refractory schizophrenics.
    Miller DD; Perry PJ; Cadoret RJ; Andreasen NC
    Compr Psychiatry; 1994; 35(1):8-15. PubMed ID: 8149734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine effects on positive and negative symptoms: a six-month trial in treatment-refractory schizophrenics.
    Lindenmayer JP; Grochowski S; Mabugat L
    J Clin Psychopharmacol; 1994 Jun; 14(3):201-4. PubMed ID: 8027417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.
    Spivak B; Shabash E; Sheitman B; Weizman A; Mester R
    J Clin Psychiatry; 2003 Jul; 64(7):755-60. PubMed ID: 12934974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
    Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
    Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.